- Home
- ADPT vs SBSI Comparison
ADPT vs SBSI Comparison
Compare ADPT & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- SBSI
- Stock Information
- Founded
- ADPT 2009
- SBSI 1960
- Country
- ADPT United States
- SBSI United States
- Employees
- ADPT N/A
- SBSI N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- SBSI Major Banks
- Sector
- ADPT Health Care
- SBSI Finance
- Exchange
- ADPT Nasdaq
- SBSI Nasdaq
- Market Cap
- ADPT 1.1B
- SBSI 898.6M
- IPO Year
- ADPT 2019
- SBSI N/A
- Fundamental
- Price
- ADPT $7.33
- SBSI $27.59
- Analyst Decision
- ADPT Strong Buy
- SBSI Hold
- Analyst Count
- ADPT 5
- SBSI 2
- Target Price
- ADPT $9.40
- SBSI $37.00
- AVG Volume (30 Days)
- ADPT 2.4M
- SBSI 164.6K
- Earning Date
- ADPT 05-01-2025
- SBSI 04-28-2025
- Dividend Yield
- ADPT N/A
- SBSI 5.21%
- EPS Growth
- ADPT N/A
- SBSI 3.19
- EPS
- ADPT N/A
- SBSI 2.91
- Revenue
- ADPT $178,957,000.00
- SBSI $254,514,000.00
- Revenue This Year
- ADPT $21.20
- SBSI $10.91
- Revenue Next Year
- ADPT $22.06
- SBSI $5.37
- P/E Ratio
- ADPT N/A
- SBSI $9.50
- Revenue Growth
- ADPT 5.10
- SBSI 5.30
- 52 Week Low
- ADPT $2.28
- SBSI $25.30
- 52 Week High
- ADPT $9.01
- SBSI $38.00
- Technical
- Relative Strength Index (RSI)
- ADPT 43.95
- SBSI 43.56
- Support Level
- ADPT $7.38
- SBSI $25.85
- Resistance Level
- ADPT $8.30
- SBSI $28.41
- Average True Range (ATR)
- ADPT 0.75
- SBSI 0.97
- MACD
- ADPT -0.04
- SBSI 0.05
- Stochastic Oscillator
- ADPT 33.85
- SBSI 53.54
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.